Time-dependent effects on contrast sensitivity, near and distance acuity: Difference in functional parameters? (Prospective, randomized pilot trial of photodynamic therapy versus full macular translocation)

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 246, Issue 5, 2008, Pages 653-659

  Ziemssen, Focke ^a   Lüke, Matthias ^a   Bartz Schmidt, Karl U ^a   Gelisken, Faik ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Age related macular degeneration; Contrast sensitivity; Full macular translocation; Near vision; Photodynamic therapy; Surgery; Visual acuity

Indexed keywords

VASCULOTROPIN INHIBITOR; VERTEPORFIN;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST SENSITIVITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; INTERMETHOD COMPARISON; PHOTODYNAMIC THERAPY; PILOT STUDY; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA TRANSLOCATION; SUBRETINAL NEOVASCULARIZATION; TREATMENT DURATION; TREATMENT OUTCOME; VISION; VISUAL ACUITY;

CHOROIDAL NEOVASCULARIZATION; CONTRAST SENSITIVITY; DISTANCE PERCEPTION; HUMANS; MACULA LUTEA; MACULAR DEGENERATION; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PILOT PROJECTS; PORPHYRINS; PROSPECTIVE STUDIES; TIME FACTORS; VISUAL ACUITY;

EID: 42049124114     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-007-0726-y     Document Type: Article

References (27)

1. Klein R, Klein BE, Linton KL (1992) Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 99:933-943
2. Arditi A, Cagenello R (1993) On the statistical reliability of letter-chart visual acuity measurements. Invest Ophthalmol Vis Sci 34:120-129
3. Elliott DB (1998) Contrast sensitivity and glare testing. In Borish BJ (eds) Clinical refraction. Butterworth-Heinemann, Woburn, Mass pp 203-241
4. Rubin FS, Bandeen-Roche K, Huang GH, Munoz B, Schein OD, Fried LP, West SK (2001) The association of multiple visual impairments with self-reported disability: SEE project. Invest Ophthalmol Vis Sci 42:64-72
5. Legge GE, Ross JA, Isenberg LM, LaMay JM (1992) Psychophysics of reading: Clinical predictors of low vision reading speed. Invest Ophthalmol Vis Sci 33:677-687
6. Bellmann C, Unnebring K, Rubin GS, Miller D, Holz FG (2003) Visual acuity and contrast sensitivity with neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 241:968-974
7. Gelisken F, Voelker M, Schwabe R et al (2007) Full macular translocation versus photodynamic therapy with verteporfin in the treatment of neovascular age-related macular degeneration: 1-year results of a prospective, controlled, randomised pilot trial (FMT-PDT). Graefes Arch Clin Exp Ophthalmol E-pub
8. Colenbrander A, Fletcher DC (1990) Visual acuity measurements in low vision patients. J Vis Rehabil 4:1-9
9. Luke M, Ziemssen F, Bartz-Schmidt KU, Gelisken F (2007) Quality of life in a prospective, randomized pilot-trial of photodynamic therapy versus full macular translocation in treatment of neovascular age-related macular degeneration - a report of 1 year results. Graefes Arch Clin Exp Ophthalmol 248:1831-1836
10. Aisenbrey S, Lafaut BA, Szurman P et al (2002) Macular translocation with 360 degrees retinotomy for exudative age-related macular degeneration. Arch Ophthalmol 120:451-459
11. Liou HW, Brennan NA (1998) Letter contrast sensitivity function of the eye. Acta Ophthalmol Scand 76:325-328
12. Yang Y, ANCHOR study group (2007) Two year contrast sensitivity results from the ANCHOR study comparing intravitreal ranbizumab 0.3 mg and 0.5 mg with verteporfin photodynamic therapy for predominantly classic CNV lesions secondary to age-related macular degeneration. Invest Ophthalmol Vis Sci 48:A4545
13. Ivers QR, Mitchell PM, Cumming RG (2000) Visual function tests, eye disease and symptoms of visual disability: A population-based assessment. Clin Exp Ophthalmol 28:41-47
14. Cusick M, SanGiovanni JP, Chew EY et al (2005) Central visual function and the NEI-VFQ-25 near and distance activities subscale scores in people with type 1 and 2 diabetes. Am J Ophthalmol 139:1042-1050
15. Cahill MT, Sinnett SS, Banks AD, Freedman SF, Toth CA (2005) Quality of life after macular translocation with 360 degrees peripheral retinectomy for age-related macular degeneration. Ophthalmology 112:144-151
16. Hazel CA, Petre KL, Armstrong RA, Benson BT, Frost NA (2000) Visual function and subjective quality of life compared in subjects with acquired macular disease. Invest Ophthalmol Vis Sci 41:1309-1315
17. McClure ME, Hart PM, Jackson AJ, Stevenson MR, Chakravarthy (2000) Macular degeneration: Do conventional measurements of impaired visual function equate with visual disability? Br J Ophthalmol 84:244-250
18. Tejeria L, Harper RA, Artes PH, Dickinson CM (2007) Face recognition in age related macular degeneration: Perceived disability, measured disability, and performance with a bioptic device. Br J Ophthalmol 86:1019-1026
19. Patel I, Turano KA, Broman AT, Bandeen-Roche K, Munoz B, West SK (2006) Measures of visual function and percentage of preferred walking speed in older adults. Invest Ophthalmol Vis Sci 47:65-71
20. Lord SR, Clark RD, Webster IW (1991) Visual acuity and contrast sensitivity in relation to falls in an elderly population. Age and Ageing 20:175-181
21. Lee HKM, Scudds RJ (2003) Comparison of balance in older people with and without visual impairment. Age and Ageing 32:643-649
22. Freeman EE, Egleston BL, West SK, Bandeen-Roche K, Rubin G (2005) Visual acuity change and mortality in older adults. Invest Ophthalmol Vis Sci 46:4040-4045
23. Lai JC, Lapolice DJ, Stinnett SS et al (2002) Visual outcomes following macular translocation with 360° peripheral retinectomy. Arch Ophthalmol 120:1317-1324
24. Fujikado T, Asonuma S, Ohji M et al (2002) Reading ability after macular translocation surgery with 360-degree retinotomy. Am J Ophthalmol 134:849-856
25. Toth CA, Lapolice DJ, Banks AD, Stinnett SS (2004) Improvement in near visual function after macular translocation surgery with 360-degree peripheral retinectomy. Graefes Arch Clin Exp Ophthalmol 242:541-548
26. Rubin GS, Bressler NM, TAP Study Group. (2002) Effects of verteporfin therapy on contrast sensitivity. Retina 22:536-544
27. Brown DM, Kaiser PK, Michels M et al (2006) Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355:1432-1444